Method
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.65% · OPTIONAL
· Retail-Drug Stores and Proprietary Stores
RESEARCH SNAPSHOTCVS HEALTH Corp's latest supported as-filed period reports revenue of $106.1B, 7.3% above the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.65% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 5.98% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 7.26% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 16.61% · OPTIONAL
Level · gp.fundamentals.operating_margin
Raw value 4.43% · CORE
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 0.17% · OPTIONAL
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed -3.9% from the comparable as-filed period.
Inventory changed +1.0% from the comparable as-filed period.
Net income changed +191.8% from the comparable as-filed period.
Operating income changed +97.5% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
CVS · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-354096SEC ↗13F-HRAug 6, 2026Period Jun 30, 20260000064803-26-000101SEC ↗10-QAug 5, 2026Period Jun 30, 20260000064803-26-000098SEC ↗8-KAug 5, 2026Period Aug 5, 20260000064803-26-000097SEC ↗4Jun 29, 2026Period Jun 26, 20260000064803-26-000092SEC ↗4Jun 1, 2026Period May 31, 20260000064803-26-000088SEC ↗4Jun 1, 2026Period May 31, 20260000064803-26-000086SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jun 26, 2026Filed Jun 29, 2026 | Clark James DavidSVP, Cont & Chief Acct Officer | Tax WithholdingDirect | 454 | $91 | $41,305 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Operating margin moved +2.03 percentage points from the comparable as-filed period.
Revenue changed +7.3% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0000064803-26-000084